News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Hans Hammers: The Werewolf Therapeutics trial with WTX-124 has opened
Hans Hammers/utswmed.org
Mar 28, 2025, 10:31

Hans Hammers: The Werewolf Therapeutics trial with WTX-124 has opened

Hans Hammers, Professor at UT Southwestern Medical Center, posted on X:

“Excited to announce that the Werewolf Therapeutics trial with WTX-124 has opened. Intriguing way to deliver effective IL-2 without hospitalizations or ICU.

Single agent activity. If you have Kidney Cancer, Lung Cancer or Melanoma / Skin cancer then get in touch!”

Tian Zhang, Associate Director of Clinical Research at Simmons Comprehensive Cancer Center and Director of Clinical Research at UT Southwestern Medical Center, shared this post on X, adding:

“Glad to have this trial speed thru activation! Enrollment is ongoing!”

Hans Hammers

cancer Hans Hammers OncoDaily Oncology Tian Zhang UTSW Simmons Cancer Center Werewolf Therapeutics trial
Special Coverage
Blog Posts
Aug 18, 2025, 18:20
Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025
Insight
Aug 18, 2025, 18:09
Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer
Voices
Aug 18, 2025, 17:43
Building a Healthier Future for Women Also Means Building a Healthier Future for the Next Generation - Elekta Foundation
Voices
Aug 18, 2025, 17:35
Mandar Muzumdar: The Evolution of Single-Cell 3D Genomes in KRAS-Driven Cancers
Blog Posts
Aug 18, 2025, 17:21
Douglas Flora: Create the Things You Wish Existed
Blog Posts
Aug 18, 2025, 17:13
Matt Yurgelun: Thrilled to Be Joining The Jimmy Fund Radio-Telethon
Voices
Aug 18, 2025, 17:04
Striking out Cancer for Patients Like Charlie - The Jimmy Fund
Insight
Aug 18, 2025, 16:52
Darren Haywood: Pleased to Receive COSA Endorsement of the MASCC COG-IMPACT Tool
Science
Aug 18, 2025, 16:48
Petros Grivas: Highlighting Intra-Patient Tumor Heterogeneity in Prostate Cancer Research
Science
Aug 18, 2025, 16:46
How Do We Select the Best 2L Therapy for Advanced EGFR‑Mutant NSCLC After Osimertinib? - Oncogene Cancer Research
Blog Posts
Aug 18, 2025, 16:37
Amanda Impellizzeri: What a Weekend at the Carolina Cancer Conference
Science
Aug 18, 2025, 16:33
Maria Tolia: New Study on Cardio-Oncology Considerations for Breast Cancer